Observational studyEpidemiology and infection2026
Incidence of skin and soft-tissue infections in England: 11-year retrospective study.
Observational study in Epidemiology and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Epidemiological estimates for the incidence of skin and soft-tissue infections (SSTIs) in England are limited. We aimed at evaluating the incidence of SSTIs and associated complications through a retrospective, observational 11-year study (2010-2020). We retrieved data on SSTI and associated complications from Clinical Practice Research Datalink, Hospital Episode Statistics, and the Office for National Statistics for England. More than four million SSTI episodes were identified, which corresponded to an overall incidence of 33.1 per 1000 person-years of observation (PYO). The incidence per 1000 PYO was highest in patients with a previous history of SSTI (109.8), ≥65 years (70.1), and those with comorbidities (69.0). The incidence of abscesses/cellulitis/other SSTIs (25.7) was the most frequent, followed by chronic ulcers (4.7) and surgical site infections (2.8). Of the 0.4 million SSTI hospitalizations, ~62.8% were due to abscesses/cellulitis/other SSTIs. Recurrences in the 12 months after the first SSTI were found in 19.5% of cases. Mortality due to SSTI and related complications varied between 0.4% and 0.5% across years, mostly in hospitalized settings. These results show that SSTIs are responsible for a substantial burden of disease in England and will help clinicians in better understanding the epidemiology of SSTI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.